An initial analysis of the UK Medical Cannabis Registry: Outcomes analysis of first 129 patients
Abstract Aim Cannabis‐based medicinal products (CBMPs) are prescribed with increased frequency, despite a paucity of high‐quality randomized controlled trials. The aim of this study is to analyze the early outcomes of the first series of patients prescribed CBMPs in the UK with respect to effects on...
Saved in:
Main Authors: | Simon Erridge (Author), Oliver Salazar (Author), Michal Kawka (Author), Carl Holvey (Author), Ross Coomber (Author), Azfer Usmani (Author), Mohammed Sajad (Author), Sushil Beri (Author), Jonathan Hoare (Author), Shaheen Khan (Author), Mark W. Weatherall (Author), Michael Platt (Author), James J. Rucker (Author), Mikael H. Sodergren (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An observational study of clinical outcome measures in patients treated with cannabis‐based medicinal products on the UK Medical Cannabis Registry
by: Simon Erridge, et al.
Published: (2023) -
UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder
by: Pim Ittiphakorn, et al.
Published: (2023) -
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes
by: Devaki Nimalan, et al.
Published: (2022) -
A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance
by: Matthew Murphy, et al.
Published: (2024) -
Clinical outcome analysis of patients with autism spectrum disorder: analysis from the UK Medical Cannabis Registry
by: Simon Erridge, et al.
Published: (2022)